Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Instil Bio, Inc. (TIL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate Update"
04/28/2023 DEFR14A Form DEFR14A - Revised definitive proxy soliciting materials:
04/24/2023 ARS Form ARS - Annual Report to Security Holders:
04/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/24/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/14/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/31/2023 8-K Quarterly results
Docs: "Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update"
03/10/2023 8-K Other Events  Interactive Data
02/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "One-Year Retention Bonus Agreement for Executive Officers"
02/14/2023 SC 13G/A RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in INSTIL BIO, INC.
02/09/2023 SC 13G/A FMR LLC reports a 9.5% stake in INSTIL BIO INC
02/01/2023 8-K Quarterly results
01/27/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
01/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Instil Bio Announces Resumption of Clinical Trial of CoStAR-TIL Candidate ITIL-306 in Lung, Ovarian, and Renal Cancer"
12/08/2022 8-K Quarterly results
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/14/2022 8-K Quarterly results
Docs: "Instil Bio Reports Third Quarter 2022 Financial Results and Provides Corporate Update"
11/08/2022 8-K Quarterly results
10/31/2022 8-K Quarterly results
10/18/2022 8-K Quarterly results
09/06/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Instil Bio Announces Appointment of Tim Moore as Chief Operating Officer"
08/12/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/12/2022 8-K Quarterly results
Docs: "Instil Bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update"
06/22/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/13/2022 8-K Quarterly results
05/27/2022 8-K Quarterly results
05/20/2022 8-K Quarterly results
05/18/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy